Betterlife Pharma Inc. income statement BETRF

Annual Quarterly

It recorded a net loss of $3.4 million. Diluted earnings per share were -$0.04.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the same quarter a year earlier.

Line	TTM Oct 31, 2018	Q3 FY2019 Oct 31, 2018	Q2 FY2019 Jul 31, 2018	Q4 FY2018 Jan 31, 2018	Q3 FY2018 Oct 31, 2017	Q2 FY2018 Jul 31, 2017	Q1 FY2018 Apr 30, 2017	Q4 FY2017 Jan 31, 2017	Q3 FY2017 Oct 31, 2016
Research and development	—	0	0	—	—	—	—	—	—
Selling, general and administrative	2 +142.6%	0 +756.6%	0 +474.8%	0 -70.0%	0 -29.2%	0 +104956.9%	0 -94.5%	1	0
Operating income	-4 -183.5%	-1 -664.6%	-1 -374.8%	-0 +59.8%	-0 +73.2%	-0 +78.9%	-0 +91.4%	-1	-1
Net income	-7 -1011.4%	-3 -736.4%	-1 -25358.0%	-0 +59.8%	1 +155.6%	-0 +99.5%	-0 +90.4%	-1	-1
Basic EPS	—	-0.04 -500.0%	—	—	0.01	—	—	—	—
Diluted EPS	—	-0.04 -500.0%	—	—	0.01	—	—	—	—
Weighted average shares, basic	—	90	—	—	—	—	—	—	—
Weighted average shares, diluted	—	90 +9.8%	—	—	82	—	—	—	—
Other measures
Depreciation and amortization	—	—	—	—	—	—	—	0	0
EBITDA	—	—	—	—	—	—	—	-1	-1
Interest coverage	-14.45x	-10.47x	-12.18x	-113.75x	-25.19x	-29.74x	-32.49x	-102.14x	-191.11x

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

New to this? Read How to Read an Income Statement, With a Real Example.

Company profile

Industry: Pharmaceutical Preparations (SIC 2834)
Listed as: BETRF (OTC)
Fiscal year ends: January 31
Incorporated in: British Columbia, Canada
Headquarters: Vancouver, British Columbia, Canada
SEC filer status: Non-accelerated filer
SEC CIK: 1464165
Former names: Pivot Pharmaceuticals Inc. (until Dec 3, 2019); Neurokine Pharmaceuticals Inc. (until Mar 26, 2015)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.